Literature DB >> 6164517

Beta 2-microglobulin and other proteins as parameter for tubular function.

M Weise, D Prüfer, G Jaques, M Keller, A W Mondorf.   

Abstract

Urinary excretion of the low molecular weight protein beta 2-microglobulin and tubular enzymes--alanine aminopeptidase (AAP), gamma-glutamyl transpeptidase (gamma-GT) and alkaline phosphatase (AP)--are very sensitive parameters for proximal tubular lesions. In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis. In the first group the increase is 3- to 4-fold and in the second group up to 300-fold. In patients with kidney transplantation the urinary excretion of beta 2-microglobulin, AAP, gamma-GT and AP are several times higher than in normals. In case of a rejection episode a further increase of these proteins occur in more than 80% several days before clinical symptoms are present. The application of analgetics (paracetamol, acetylsalicylic acid) in healthy individuals in therapeutical dosages on 3 consecutive days does not show any tubular alteration by the measurement of urinary beta 2-microglobulin. Aminoglycosides (tobramycin, UK 18,892) lead to a cumulative increase of the renal excretion of beta 2-microglobulin and AAP while cephalosporins induce an increase of total proteins in the final urine under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164517     DOI: 10.1159/000395233

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  2 in total

1.  Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.

Authors:  E H Cooper; M A Forbes; R A Crockson; I C MacLennan
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

2.  Development of a multiplex mass spectrometry method for simultaneous quantification of urinary proteins related to respiratory health.

Authors:  Sarah J D Nauwelaerts; Nancy H C Roosens; Alfred Bernard; Sigrid C J De Keersmaecker; Koen De Cremer
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.